Primary osteoporosis
Conditions
Interventions
Control group:Standard Western medicine treatment for primary osteoporosis
Experimental group:''Bushen Qianggu decoction'' combined with standard protocol of Western medicine treatment for primary osteoporosis
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
All
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Dual-energy X-ray bone mineral density examination: minimum bone mineral density T-value of lumbar spine, femoral neck or total hip <=2.5. 2. Any one of the symptoms in the TCM symptom grading scale of osteoporosis is present and the score is moderate or above. 3. TCM syndrome differentiation is ''deficiency of kidney Yang syndrome''. 4. Aged 50-80 years. 5. Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with secondary osteoporosis (unstable primary disease). 2. Patients with mental diseases or cognitive dysfunction. 3. Received anti-osteoporosis drug therapy within 3 years of study inclusion for at least 6 months. 4. Patients with allergies or contraindications to the drugs used in the study. 5. Significantly abnormal liver and kidney function (indication: AST or ALT>=2.5 times the upper limit of normal, eGFR<=60ml/min.1.73m^2). 6. History of tumors, heart, brain, kidney and other serious organ diseases (except thyroid and early breast cancer). 7. The patient's symptoms, such as low back pain, are caused by causes other than osteoporosis. 8. The researcher believes that the patient is not suitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of improvement in quality of life ;Bone metabolism biomarkers;Evaluation of clinical efficacy according to ''Clinical Guiding Principles of New Chinese traditional Medicine'';Liver and kidney function;Urological ultrasound (Whether there are stones or not); | — |
Countries
China
Contacts
Public ContactMa Xiao, Bu Shi
China-Japan Friendship Hospital
Outcome results
None listed